Frazier Management’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
Other funds holding COGT
EAM
CC
PA
TCM
FLSM
VC
CS
GTC
Frazier Management's COGT Position: Q1 2022 in Review
Frazier Management sold out of Cogent Biosciences (COGT) in Q1 2022, closing a stake of 1,774,891 shares — an estimated $15.2M sold.
Frazier Management first reported a position in COGT in Q4 2021 and held it in 1 quarter. The position peaked at $15.2M in Q4 2021. 87 funds tracked by Wall St. Rank hold COGT as of Q1 2022.
- Frazier Management reported no remaining Cogent Biosciences position as of Q1 2022 after selling out during the quarter.
- Frazier Management sold 1,774,891 Cogent Biosciences shares in Q1 2022, an estimated $15.2M.
- Frazier Management first reported a position in Cogent Biosciences in Q4 2021 and held it in 1 quarter.
- Frazier Management's Cogent Biosciences position peaked at $15.2M in Q4 2021.
- 87 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2022.
Based on Frazier Management's 13F filing for Q1 2022, filed 13 May 2022.